IP Library Granted Patent US 12,091,381
Granted Patent B2
US 12,091,381 · App. 18/080,163 · Granted Sep 17, 2024

Production and separation of 3-hydroxypropionic acid

Inventors: Jeung Yeop Shim (Tampa, FL); Ki Soo Park (Yongin, KR); Ashok Somasundar (Suwon, KR); Sung Hoon Park (Ulsan, KR)
Assignee: Noroo IC Co., Ltd.
C07C51/48B01D11/04C07C51/377C07C59/01C12N15/78B01D5/0027B01D17/0214C07C57/04C12N2830/002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,091,381
App. No.
18/080,163
Granted
Sep 17, 2024
Kind
B2
Abstract

The disclosure provides methods and apparatus for producing 3-hydroxypropionic acid or a salt thereof, for removing 3-hydroxypropionic acid from aqueous solution (e.g., aqueous broth), and for using it to make various chemicals.

Claims (3)

1. An expression system, comprising a first promoter that is either constitutive or inducible by a small molecule, a second promoter that is either constitutive or induced by a small molecule, a first gene encoding a protein involved in the synthesis of 3-HP, a salt of 3-HP, or coenzyme B12, a modified UTR, and a native sequence encoding up to 20 amino acids from the N-terminus of a native Pseudomonas denitrificans protein, wherein the native sequence is operably linked to the 3′-terminus of the modified UTR and operably linked to the 5′-terminus of the first gene, the first and second promoters are operably linked in tandem upstream of the modified UTR, and the modified UTR comprises a sequence selected from the group consisting of SEQ ID NO: 22-28 and 64 (UTR0-6).

2. The expression system of claim 1 , further comprising a third promoter; and a second gene encoding a transcriptional regulator configured to regulate expression of the first gene, wherein the third promoter is operably connected to the second gene, and the third promoter comprises a sequence that is 95% identical to the sequence selected from the group consisting of SEQ ID NO: 7-10 and 52-63.

3. The expression system of claim 1 , wherein the first promoter is operably linked to the 5′-terminus of the second promoter, the second promoter is operably linked to the 5′-terminus of the modified UTR, and the modified UTR is operably linked to the 5′terminus of the fusion gene.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2022
From: SHIM, JEUNG YEOP; PARK, KI SOO; SOMASUNDAR, ASHOK; PARK, SUNG HOON
To: NOROO HOLDINGS CO., LTD.
Reel/Frame 062223/0958 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2022
From: NOROO HOLDINGS CO., LTD.
To: NOROO IC CO. LTD.
Reel/Frame 062224/0151 →
CHANGE OF NAME Recorded Dec 28, 2022
From: NOROO IC CO. LTD.
To: NOROO IC CO., LTD.
Reel/Frame 062232/0913 →
Continuity (5)
Division 16858065 · Apr 24, 2020
Continuation 16758815
Provisional Application 62594318 · Dec 4, 2017
Provisional Application 62577361 · Oct 26, 2017
Related Publication 20230151375A1 · May 18, 2023
Cited By (1)
US 12,486,212